FIELD: chemistry.
SUBSTANCE: invention describes compounds of formula 2 and 3
, synthesis methods thereof, pharmaceutical compositions, as well as use thereof to prepare a medicinal agent, having antagonistic activity towards D2-receptors and modulating activity towards 5HT reuptake.
EFFECT: present invention provides salt forms used as modulators of one or more GPCR.
20 cl, 3 tbl, 5 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| -E-10-OH-NT COMPOSITIONS AND METHOD FOR SYNTHESIS AND USE THEREOF | 2008 |
|
RU2469715C2 |
| SOLID FORMS CONTAINING (-)-O-DESMETHYLVENLAFAXINE AND USE THEREOF | 2008 |
|
RU2477269C2 |
| SUBSTITUTED 6-(1-PIPERAZINYL)-PYRIDAZINES AS 5-HT6 RECEPTOR ANTAGONISTS | 2009 |
|
RU2502734C2 |
| PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT OR PREVENTION OF DISORDER OF CENTRAL NERVOUS SYSTEM | 2017 |
|
RU2776800C2 |
| CHIMERIC POLYPEPTIDE SELECTIVELY REACTING WITH RELATED CHEMOKINE RECEPTOR, PHARMACEUTICAL COMPOSITION AND APPLICATION OF CHIMERIC POLYPEPTIDE (VERSIONS) | 2005 |
|
RU2430113C2 |
| ORGANIC COMPOUNDS | 2017 |
|
RU2743513C2 |
| NOVEL FUMARATE SALTS OF H3 HISTAMINE RECEPTOR ANTAGONISTS | 2010 |
|
RU2537847C2 |
| 1,2,4-TRIAZOLO[4,3-A]PYRIDINE COMPOUNDS AND USE THEREOF AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS | 2015 |
|
RU2695651C2 |
| VORTIOXYETINE PYROGLUTAMATE | 2016 |
|
RU2713889C2 |
| LIGAND WITH WIDE RANGE OF SIMULTANEOUS RECEPTOR ACTIVITY, PHARMACEUTICAL COMPOSITION, METHOD OF PREPARING SAID COMPOSITION AND MEDICINAL AGENT | 2008 |
|
RU2374245C1 |
